Gowen Maxine
SEC-identified person · CIK 1280044 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aclaris Therapeutics, Inc. ACRS | Director | filed 2019 - 2026 |
| Passage BIO, Inc. PASG | Director | filed 2021 - 2026 |
| Merus N.V. MRUS | Director | filed 2021 - 2025 |
| Idera Pharmaceuticals, INC. IDRA | Director | filed 2016 - 2023 |
| Akebia Therapeutics, Inc. AKBA | Director | filed 2014 - 2020 |
| Trevena INC TRVN | Director · President & CEO | filed 2014 - 2020 |
| Human Genome Sciences INC HGSI | Director | filed 2008 - 2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.